Graham Capital Management’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-51,072	Closed	-$450K	–	1320
2025 Q3	$450K	Buy	51,072 +11,812	+30%	+$91.9K	0.02%	655
2025 Q2	$250K	Buy	+39,260	New	+$225K	0.01%	1054
2024 Q4	–	Sell	-36,692	Closed	-$306K	–	1296
2024 Q3	$306K	Sell	36,692 -7,183	-16%	-$65.3K	0.01%	773
2024 Q2	$299K	Buy	+43,875	New	+$189K	0.01%	733
2024 Q1	–	Sell	-36,637	Closed	-$87.9K	–	1129
2023 Q4	$87.9K	Buy	36,637 +23,986	+190%	+$56.4K	﹤0.01%	913
2023 Q3	$43K	Buy	+12,651	New	+$70.1K	﹤0.01%	969
2022 Q3	–	Sell	-6,626	Closed	-$205K	–	1119
2022 Q2	$205K	Sell	6,626 -4,493	-40%	-$153K	0.01%	920
2022 Q1	$456K	Buy	+11,119	New	+$490K	0.02%	584